Supplementary Figure 1 from A Phase I/II Study of the Mtor Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

Naval Daver, Yanis Boumber, Hagop M. Kantarjian, Farhad Ravandi,Jorge E. Cortés,Michael Rytting,Jitesh D. Kawedia,Jordan Basnett,Kirk S. Culotta,Zhihong Zeng, Hongzhou Lu,Mary Ann Richie,Rebecca Garris, Lianchun Xiao, Wenbin Liu,Keith A. Baggerly,Elias Jabbour, Susan O’Brien,Jan A. Burger,Linda J. Bendall, Deborah A. Thomas,Marina Konopleva

openalex（2023）

引用 0|浏览2

暂无评分

关键词

Therapeutic Targets

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要